Hemogenyx

Developer of cell and gene therapies to treat blood diseases and viral infections

placeBuffalo, New York, United States calendar_todayFounded 2014 groups14 employees language hemogenyx.com

Registered entities

Innovation

3 patent families — focus: Chemistry & metallurgy; filing pace slowing. Cited 9 times.

YearFilings
20171
20192
20211

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital480%
Other / undisclosed120%
Coming soon